HLK secures substantial costs award for Establishment Labs at the UPC
We’re pleased to have achieved a strong result for our client Establishment Labs S.A. in a recent UPC infringement action brought by CooperSurgical.
After the patent at issue was revoked by the EPO, CooperSurgical withdrew its UPC case and argued that each party should bear its own costs. The UPC disagreed and held that a withdrawing claimant, especially following EPO revocation, should be treated as the unsuccessful party, awarding Establishment Labs substantial costs.
